PHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2020
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2020 |
| Quarter | 4 Qtr |
| Quarterly report for the financial period ended | 31 Dec 2020 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
31 Dec 2020
|
31 Dec 2019
|
31 Dec 2020
|
31 Dec 2019
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
634,583
|
715,683
|
2,725,071
|
2,820,530
|
| 2 | Profit/(loss) before tax |
-13,506
|
-238,474
|
35,793
|
-191,865
|
| 3 | Profit/(loss) for the period |
-7,047
|
-178,733
|
26,269
|
-149,447
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
-6,331
|
-178,598
|
27,489
|
-149,219
|
| 5 | Basic earnings/(loss) per share (Subunit) |
-2.42
|
-68.45
|
10.51
|
-57.19
|
| 6 | Proposed/Declared dividend per share (Subunit) |
1.00
|
0.00
|
11.00
|
8.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.2900
|
1.2900
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 17 Mar 2021 |
| Category | Financial Results |
| Reference Number | FRA-18022021-00014 |